Hyperglycemia, dyslipidemia and hypertension in older people with diabetes: the benefits of cardiovascular risk reduction

By Brown Siobhan HM   Abdelhafiz Ahmed H  

Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. : 515-529

Future Medicine

Access to resources Recommend Favorite

Early insulin therapy and the risk of cardiovascular disease in Type 2 diabetes

By Nicasio John   McFarlane Samy I  

Therapy, Vol. 2, Iss. 5, 2005-09 ,pp. : 685-688

Future Medicine

Access to resources Recommend Favorite

Perceptions of Benefit of Complementary Therapy Use among People with Diabetes and Cardiovascular Disease

By  

Forschende Komplementärmedizin / Research in Complementary Medicine, Vol. 21, Iss. 1, 2014-02 ,pp. : 25-33

Karger

Access to resources Recommend Favorite

Modeling effects of SGLT‐2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 16, Iss. 7, 2014-07 ,pp. : 628-635

John Wiley & Sons Inc

Access to resources Recommend Favorite

How safe is metabolic/diabetes surgery?

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 2, 2015-02 ,pp. : 198-201

John Wiley & Sons Inc

Access to resources Recommend Favorite